Level C· Early human research exploring benefitsCase Report / SeriesPubMed

Intradiscal Injection of Minimally Manipulated Adipose Tissue for Disc-Driven Cervical Myelopathy: A Case Report With Three-Year Follow-Up.

Yoon Y., Hwang J., Lee J., Lim J., Suryadi T., Suhaimi A.

Case Report / Series on Back & Spine, published in Cureus (2026) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Cureus (2026)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
42164219
DOI
10.7759/cureus.107314

Abstract (original English)

Cervical myelopathy is a progressive condition caused by spinal cord compression, for which surgical decompression is considered the standard treatment. However, alternative minimally invasive options are needed for patients who decline surgery. We report the case of a 53-year-old female who presented with progressive hand clumsiness, lower extremity weakness, and gait disturbance. She was diagnosed with cervical myelopathy at three tertiary referral centers, where surgical decompression was recommended, but she declined surgery. Imaging revealed a multilevel disc protrusion with spinal cord compression and signal change. An initial fluoroscopy-guided provocative discography with contrast was performed at C4-5, C5-6, and C6-7. No fluoroscopic evidence of extra-annular leakage was observed. Following intradiscal confirmation, lidocaine was administered as part of the diagnostic procedure, which reproduced the patient's typical symptoms at C4-5 and C5-6 and was followed by temporary symptom relief, thereby identifying the clinically relevant segments. Subsequently, minimally manipulated adipose tissue (MFAT) was injected into the C4-5 and C5-6 discs under fluoroscopic guidance. At six months, follow-up radiographs suggested possible partial restoration of disc space height at the treated levels, although this observation was qualitative and may have been influenced by positional

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research